CEO of Repligen Corp (30-Year Financial, Insider Trades) Anthony Hunt (insider trades) sold 45,351 shares of RGEN on 09/10/2020 at an average price of $148.2 a share. The total sale was $6.7 million.
Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen Corp has a market cap of $7.6 billion; its shares were traded at around $144.66 with a P/E ratio of 249.41 and P/S ratio of 25.27. Repligen Corp had annual average EBITDA growth of 19.90% over the past five years. GuruFocus has detected 2 severe warning signs with Repligen Corp. .
CEO Recent Trades:
- CEO Anthony Hunt sold 45,351 shares of RGEN stock on 09/10/2020 at the average price of $148.2. The price of the stock has decreased by 2.39% since.
For the complete insider trading history of RGEN, click here
.
